Aster DM Healthcare Financial Statements
Aster DM Healthcare Profit & Loss Statement
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 30 | 13.30 | -- | -- |
| Op profit growth | 105 | 84.50 | -- | -- |
| EBIT growth | 95.60 | 688 | -- | -- |
| Net profit growth | 2.88 | 164 | -- | -- |
| Profitability ratios (%) | ||||
| OPM | 14.40 | 9.12 | 5.60 | -- |
| EBIT margin | 8.12 | 5.40 | 0.78 | -- |
| Net profit margin | 3.17 | 4 | 1.72 | -- |
| RoCE | 9.13 | 6.60 | -- | -- |
| RoNW | 2.27 | 2.86 | -- | -- |
| RoA | 0.89 | 1.22 | -- | -- |
| Per share ratios () | ||||
| EPS | 6.30 | 5.58 | 2.42 | -- |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | (6.20) | (0.60) | (5.50) | -- |
| Book value per share | 65.50 | 56.10 | 46.50 | -- |
| Valuation ratios | ||||
| P/E | 15.20 | 30 | -- | -- |
| P/CEPS | (15) | (293) | -- | -- |
| P/B | 1.46 | 2.98 | -- | -- |
| EV/EBIDTA | 7.87 | 15.90 | -- | -- |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | (4.40) | (15) | 3.52 | -- |
| Liquidity ratios | ||||
| Debtor days | 81.70 | 77 | -- | -- |
| Inventory days | 33.20 | 31.30 | -- | -- |
| Creditor days | (72) | (64) | -- | -- |
| Leverage ratios | ||||
| Interest coverage | (2) | (2) | (0.10) | -- |
| Net debt / equity | 1.66 | 0.72 | 1.39 | -- |
| Net debt / op. profit | 4.32 | 3.35 | 7.85 | -- |
| Cost breakup () | ||||
| Material costs | (30) | (31) | (32) | -- |
| Employee costs | (33) | (34) | (35) | -- |
| Other costs | (22) | (26) | (28) | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Revenue | 8,739 | 6,721 | 5,931 | -- |
| yoy growth (%) | 30 | 13.30 | -- | -- |
| Raw materials | (2,635) | (2,059) | (1,887) | -- |
| As % of sales | 30.20 | 30.60 | 31.80 | -- |
| Employee costs | (2,904) | (2,271) | (2,055) | -- |
| As % of sales | 33.20 | 33.80 | 34.60 | -- |
| Other costs | (1,941) | (1,778) | (1,657) | -- |
| As % of sales | 22.20 | 26.50 | 27.90 | -- |
| Operating profit | 1,258 | 613 | 332 | -- |
| OPM | 14.40 | 9.12 | 5.60 | -- |
| Depreciation | (586) | (298) | (322) | -- |
| Interest expense | (360) | (185) | (354) | -- |
| Other income | 37.90 | 47.70 | 36.40 | -- |
| Profit before tax | 350 | 178 | (308) | -- |
| Taxes | (15) | (26) | (11) | -- |
| Tax rate | (4.40) | (15) | 3.52 | -- |
| Minorities and other | (38) | (13) | 4.23 | -- |
| Adj. profit | 296 | 139 | (314) | -- |
| Exceptional items | (20) | 130 | 416 | -- |
| Net profit | 277 | 269 | 102 | -- |
| yoy growth (%) | 2.88 | 164 | -- | -- |
| NPM | 3.17 | 4 | 1.72 | -- |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Profit before tax | 350 | 178 | (308) | -- |
| Depreciation | (586) | (298) | (322) | -- |
| Tax paid | (15) | (26) | (11) | -- |
| Working capital | 508 | -- | -- | -- |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 257 | (146) | -- | -- |
| Capital expenditure | 4,703 | -- | -- | -- |
| Free cash flow | 4,960 | (146) | -- | -- |
| Equity raised | 4,065 | 4,385 | -- | -- |
| Investments | 2.03 | -- | -- | -- |
| Debt financing/disposal | 2,973 | 110 | -- | -- |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 11,999 | 4,349 | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | 874 | 880 | 880 | 841 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 2,398 | 2,334 | 1,952 | 1,034 |
| Net worth | 3,272 | 3,214 | 2,832 | 1,875 |
| Minority interest | ||||
| Debt | 5,605 | 2,788 | 2,352 | 2,758 |
| Deferred tax liabilities (net) | 374 | 349 | 300 | 144 |
| Total liabilities | 9,698 | 6,818 | 5,842 | 5,152 |
| Fixed assets | 7,860 | 4,839 | 4,140 | 3,809 |
| Intangible assets | ||||
| Investments | 34.40 | 22.10 | 37.70 | 32.30 |
| Deferred tax asset (net) | 252 | 208 | 163 | 3.03 |
| Net working capital | 1,375 | 1,407 | 1,202 | 1,155 |
| Inventories | 961 | 732 | 627 | 526 |
| Inventory Days | 40.10 | -- | 34.10 | 32.30 |
| Sundry debtors | 2,366 | 2,029 | 1,546 | 1,288 |
| Debtor days | 98.80 | -- | 84 | 79.20 |
| Other current assets | 1,007 | 965 | 828 | 997 |
| Sundry creditors | (1,818) | (1,387) | (1,146) | (1,003) |
| Creditor days | 75.90 | -- | 62.20 | 61.70 |
| Other current liabilities | (1,141) | (932) | (655) | (652) |
| Cash | 177 | 341 | 300 | 152 |
| Total assets | 9,698 | 6,818 | 5,842 | 5,152 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Dec-2020 | Sep-2020 | Jun-2020 | Mar-2020 | Dec-2019 |
|---|---|---|---|---|---|
| Gross Sales | 2,259 | 2,268 | 1,761 | 2,301 | 2,322 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 2,259 | 2,268 | 1,761 | 2,301 | 2,322 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 6.72 | 8.97 | 7.54 | 26.80 | 4.18 |
| Total Income | 2,266 | 2,277 | 1,768 | 2,328 | 2,326 |
| Total Expenditure ** | 1,931 | 1,997 | 1,618 | 1,899 | 1,955 |
| PBIDT | 335 | 280 | 150 | 429 | 371 |
| Interest | 62.10 | 74.60 | 80.30 | 112 | 71.50 |
| PBDT | 273 | 205 | 70 | 317 | 299 |
| Depreciation | 157 | 153 | 155 | 171 | 140 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 5.92 | 6.92 | 4.74 | 14.40 | 4.65 |
| Deferred Tax | 1.86 | 3.40 | (0.90) | (14) | 3.59 |
| Reported Profit After Tax | 107 | 42.30 | (89) | 146 | 151 |
| Minority Interest After NP | 15 | 9.39 | (5.70) | 15.20 | 12.30 |
| Net Profit after Minority Interest | 92.40 | 32.90 | (83) | 131 | 139 |
| Extra-ordinary Items | -- | -- | -- | (1.10) | (17) |
| Adjusted Profit After Extra-ordinary item | 92.40 | 32.90 | (83) | 132 | 157 |
| EPS (Unit Curr.) | 1.86 | 0.66 | (1.70) | 2.61 | 2.78 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 500 | 500 | 500 | 500 | 505 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 14.80 | 12.30 | 8.54 | 18.70 | 16 |
| PBDTM(%) | 12.10 | 9.06 | 3.98 | 13.80 | 12.90 |
| PATM(%) | 4.76 | 1.86 | (5) | 6.36 | 6.52 |
QuickLinks for Aster DM Healthcare Ltd.
